Optiscan live with FIVE 1
Thursday, 12 June, 2008
Australian confocal microscopy specialist Optiscan Imaging (ASX: OIL) is expanding the global market for its endomicroscopes, including setting up a US sales office to further awareness of its FIVE 1 endomicroscope for pre-clinical research.
FIVE 1, or fluorescence in vivo endomicroscopy, is aimed at cellular research, including stem cell and tissue regeneration research.
Optiscan also has a partnership with Pentax to develop flexible endomicroscopes, which are being used in a global clinical trial.
Optiscan has set up a sales office in San Diego, California, and has distributors throughout Europe and Asia.
'Woolly mouse' created on the quest to bring back the mammoth
By modifying seven genes simultaneously, Colossal created mice with a coat colour, texture and...
Biotherapeutics: what do we make next?
Two recent AI methods, RFdiffusion and ProteinMPNN, have totally changed the nature of...
Targeted therapy for childhood brain cancer shows promise
A potential new targeted therapy for childhood brain cancer is effective in infiltrating and...
